N⁴-octadecyl-1-[beta]-D-arabinofuranosylcytosine (NOAC), a new anticancer drug
Subtitle: pharmacokinetics and metabolism inmice, distribution in human blood, uptake and cytotoxicity in lymphoma cells
By: Sibylle Klara Maria Koller-Lucae
Contributors: Eidgenössische Technische Hochschule Zürich
Published: 1998
Language: eng
Notes: Thesis (doctoral)--Swiss Federal Institute of Technology Zurich, 1998.